A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady State
Clinical trial NCT02608034 · COMPLETED
Trial details
- NCT number
- NCT02608034
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-26
- Primary completion
- 2018-09-10
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.